These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
219 related articles for article (PubMed ID: 23890378)
1. Time to recurrence is a significant predictor of cancer-specific survival after recurrence in patients with recurrent renal cell carcinoma--results from a comprehensive multi-centre database (CORONA/SATURN-Project). Brookman-May SD; May M; Shariat SF; Novara G; Zigeuner R; Cindolo L; De Cobelli O; De Nunzio C; Pahernik S; Wirth MP; Longo N; Simonato A; Serni S; Siracusano S; Volpe A; Morgia G; Bertini R; Dalpiaz O; Stief C; Ficarra V; ; ; BJU Int; 2013 Nov; 112(7):909-16. PubMed ID: 23890378 [TBL] [Abstract][Full Text] [Related]
2. Features associated with recurrence beyond 5 years after nephrectomy and nephron-sparing surgery for renal cell carcinoma: development and internal validation of a risk model (PRELANE score) to predict late recurrence based on a large multicenter database (CORONA/SATURN Project). Brookman-May S; May M; Shariat SF; Xylinas E; Stief C; Zigeuner R; Chromecki T; Burger M; Wieland WF; Cindolo L; Schips L; De Cobelli O; Rocco B; De Nunzio C; Feciche B; Truss M; Gilfrich C; Pahernik S; Hohenfellner M; Zastrow S; Wirth MP; Novara G; Carini M; Minervini A; Simeone C; Antonelli A; Mirone V; Longo N; Simonato A; Carmignani G; Ficarra V; Eur Urol; 2013 Sep; 64(3):472-7. PubMed ID: 22748912 [TBL] [Abstract][Full Text] [Related]
3. Chromophobe renal cell carcinoma (RCC): oncological outcomes and prognostic factors in a large multicentre series. Volpe A; Novara G; Antonelli A; Bertini R; Billia M; Carmignani G; Cunico SC; Longo N; Martignoni G; Minervini A; Mirone V; Simonato A; Terrone C; Zattoni F; Ficarra V; ; BJU Int; 2012 Jul; 110(1):76-83. PubMed ID: 22044519 [TBL] [Abstract][Full Text] [Related]
4. Impact of tumour location versus multifocality in patients with upper tract urothelial carcinoma treated with nephroureterectomy and bladder cuff excision: a homogeneous series without perioperative chemotherapy. Yafi FA; Novara G; Shariat SF; Gupta A; Matsumoto K; Walton TJ; Fritsche HM; El-Hakim A; Trischler S; Martínez-Salamanca JI; Seitz C; Ficarra V; Zattoni F; Karakiewicz PI; Kassouf W BJU Int; 2012 Jul; 110(2 Pt 2):E7-13. PubMed ID: 22177329 [TBL] [Abstract][Full Text] [Related]
6. Prognostic factors in a large multi-institutional series of papillary renal cell carcinoma. Zucchi A; Novara G; Costantini E; Antonelli A; Carini M; Carmignani G; Cosciani Cunico S; Fontana D; Longo N; Martignoni G; Minervini A; Mirone V; Porena M; Roscigno M; Schiavina R; Simeone C; Simonato A; Siracusano S; Terrone C; Ficarra V BJU Int; 2012 Apr; 109(8):1140-6. PubMed ID: 21871053 [TBL] [Abstract][Full Text] [Related]
7. Late recurrence of renal cell carcinoma >5 years after surgery: clinicopathological characteristics and prognosis. Park YH; Baik KD; Lee YJ; Ku JH; Kim HH; Kwak C BJU Int; 2012 Dec; 110(11 Pt B):E553-8. PubMed ID: 22578274 [TBL] [Abstract][Full Text] [Related]
8. Impact of clinical and histopathological parameters on disease specific survival in patients with collecting duct renal cell carcinoma: development of a disease specific risk model. May M; Ficarra V; Shariat SF; Zigeuner R; Chromecki T; Cindolo L; Burger M; Gunia S; Feciche B; Wenzl V; Aziz A; Chun F; Becker A; Pahernik S; Simeone C; Longo N; Zucchi A; Antonelli A; Mirone V; Stief C; Novara G; Brookman-May S; ; J Urol; 2013 Aug; 190(2):458-63. PubMed ID: 23434943 [TBL] [Abstract][Full Text] [Related]
9. Time to recurrence after nephrectomy as a predictor of cancer-specific survival in localized clear-cell renal cell carcinoma. Rodriguez-Covarrubias F; Gomez-Alvarado MO; Sotomayor M; Castillejos-Molina R; Mendez-Probst CE; Gabilondo F; Feria-Bernal G Urol Int; 2011; 86(1):47-52. PubMed ID: 20814191 [TBL] [Abstract][Full Text] [Related]
10. Survival and impact of clinical prognostic factors in surgically treated metastatic renal cell carcinoma. Tosco L; Van Poppel H; Frea B; Gregoraci G; Joniau S Eur Urol; 2013 Apr; 63(4):646-52. PubMed ID: 23041360 [TBL] [Abstract][Full Text] [Related]
11. Long-term outcome of small, organ-confined renal cell carcinoma (RCC) is not always favourable. Shindo T; Masumori N; Kobayashi K; Fukuta F; Hirobe M; Tonooka A; Hasegawa T; Kitamura H; Tsukamoto T BJU Int; 2013 May; 111(6):941-5. PubMed ID: 23350965 [TBL] [Abstract][Full Text] [Related]
12. Oncological efficacy and safety of nephron-sparing surgery for selected patients with locally advanced renal cell carcinoma. Margulis V; Tamboli P; Jacobsohn KM; Swanson DA; Wood CG BJU Int; 2007 Dec; 100(6):1235-9. PubMed ID: 17979923 [TBL] [Abstract][Full Text] [Related]
13. Microvascular and lymphovascular tumour invasion are associated with poor prognosis and metastatic spread in renal cell carcinoma: a validation study in clinical practice. Bedke J; Heide J; Ribback S; Rausch S; de Martino M; Scharpf M; Haitel A; Zimmermann U; Pechoel M; Alkhayyat H; Shariat SF; Dombrowski F; Stenzl A; Burchardt M; Klatte T; Kroeger N BJU Int; 2018 Jan; 121(1):84-92. PubMed ID: 28803448 [TBL] [Abstract][Full Text] [Related]
14. Clinicopathological characteristics and prognosis of patients according to recurrence time after radical nephrectomy for localized renal cell carcinoma: a multicenter study of Anatolian Society of Medical Oncology (ASMO). Bozkurt O; Inanc M; Hacibekıroglu I; Esbah O; Seker M; Ulas A; Aydin K; Uysal M; Kücüköner M; Uncu D; Cıltas A; Unal OÜ; Durnali A; Demırcı U; Berk V; Tonyali O; Oksüzoglu B; Karaca H; Ozkan M Anticancer Res; 2014 Aug; 34(8):4463-70. PubMed ID: 25075086 [TBL] [Abstract][Full Text] [Related]
15. Prognostic factors influencing long-term survival of patients undergoing nephron-sparing surgery for nonmetastatic renal-cell carcinoma (RCC) with imperative indications. Haferkamp A; Kurosch M; Pritsch M; Hatiboglu G; Macher-Goeppinger S; Pfitzenmaier J; Pahernik S; Wagener N; Hohenfellner M Ann Surg Oncol; 2010 Feb; 17(2):544-51. PubMed ID: 19953334 [TBL] [Abstract][Full Text] [Related]
16. Radiofrequency ablation versus partial nephrectomy in patients with solitary clinical T1a renal cell carcinoma: comparable oncologic outcomes at a minimum of 5 years of follow-up. Olweny EO; Park SK; Tan YK; Best SL; Trimmer C; Cadeddu JA Eur Urol; 2012 Jun; 61(6):1156-61. PubMed ID: 22257424 [TBL] [Abstract][Full Text] [Related]
17. Impact of venous tumour thrombus consistency (solid vs friable) on cancer-specific survival in patients with renal cell carcinoma. Bertini R; Roscigno M; Freschi M; Strada E; Angiolilli D; Petralia G; Matloob R; Sozzi F; Capitanio U; Da Pozzo LF; Colombo R; Guazzoni G; Cremonini A; Montorsi F; Rigatti P Eur Urol; 2011 Aug; 60(2):358-65. PubMed ID: 21640483 [TBL] [Abstract][Full Text] [Related]
18. Type II papillary histology predicts poor outcome in patients with renal cell carcinoma and vena cava thrombus. Kim KH; You D; Jeong IG; Kwon TW; Cho YM; Hong JH; Ahn H; Kim CS BJU Int; 2012 Dec; 110(11 Pt B):E673-8. PubMed ID: 22973869 [TBL] [Abstract][Full Text] [Related]
19. Relation of microvessel density with microvascular invasion, metastasis and prognosis in renal cell carcinoma. Yildiz E; Ayan S; Goze F; Gokce G; Gultekin EY BJU Int; 2008 Mar; 101(6):758-64. PubMed ID: 18070177 [TBL] [Abstract][Full Text] [Related]
20. Microscopic venous invasion in renal cell carcinoma as a predictor of recurrence after radical surgery. Ishimura T; Sakai I; Hara I; Eto H; Miyake H Int J Urol; 2004 May; 11(5):264-8. PubMed ID: 15147540 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]